Posts Tagged ‘pain’

Trevena IPO sneaks back with a “better morphine”

Whirly lollipop on orange background.

Trevena (TRVN) is another biotechnology name that jumped on the busy IPO calendar after failing to get their deal priced late in 2013. This time the terms have been set at $7/share versus the prior $12 to $14. Existing investors may participate in the IPO up to $15M which is a good portion of the…

Read More